PMID- 23000900 OWN - NLM STAT- MEDLINE DCOM- 20121226 LR - 20211021 IS - 1476-4687 (Electronic) IS - 0028-0836 (Print) IS - 0028-0836 (Linking) VI - 491 IP - 7422 DP - 2012 Nov 1 TI - Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. PG - 125-8 LID - 10.1038/nature11433 [doi] AB - In mammals, one of the most pronounced consequences of viral infection is the induction of type I interferons, cytokines with potent antiviral activity. Schlafen (Slfn) genes are a subset of interferon-stimulated early response genes (ISGs) that are also induced directly by pathogens via the interferon regulatory factor 3 (IRF3) pathway. However, many ISGs are of unknown or incompletely understood function. Here we show that human SLFN11 potently and specifically abrogates the production of retroviruses such as human immunodeficiency virus 1 (HIV-1). Our study revealed that SLFN11 has no effect on the early steps of the retroviral infection cycle, including reverse transcription, integration and transcription. Rather, SLFN11 acts at the late stage of virus production by selectively inhibiting the expression of viral proteins in a codon-usage-dependent manner. We further find that SLFN11 binds transfer RNA, and counteracts changes in the tRNA pool elicited by the presence of HIV. Our studies identified a novel antiviral mechanism within the innate immune response, in which SLFN11 selectively inhibits viral protein synthesis in HIV-infected cells by means of codon-bias discrimination. FAU - Li, Manqing AU - Li M AD - Section of Molecular Biology, Division of Biological Sciences, University of California San Diego, La Jolla, California 92093, USA. FAU - Kao, Elaine AU - Kao E FAU - Gao, Xia AU - Gao X FAU - Sandig, Hilary AU - Sandig H FAU - Limmer, Kirsten AU - Limmer K FAU - Pavon-Eternod, Mariana AU - Pavon-Eternod M FAU - Jones, Thomas E AU - Jones TE FAU - Landry, Sebastien AU - Landry S FAU - Pan, Tao AU - Pan T FAU - Weitzman, Matthew D AU - Weitzman MD FAU - David, Michael AU - David M LA - eng GR - R21 AI081019/AI/NIAID NIH HHS/United States GR - AI074967/AI/NIAID NIH HHS/United States GR - P01AI090935/AI/NIAID NIH HHS/United States GR - P30AI36214/AI/NIAID NIH HHS/United States GR - R21AI088490/AI/NIAID NIH HHS/United States GR - R01GM101982/GM/NIGMS NIH HHS/United States GR - R21 AI088490/AI/NIAID NIH HHS/United States GR - AI81019/AI/NIAID NIH HHS/United States GR - P30 AI036214/AI/NIAID NIH HHS/United States GR - R01 GM101982/GM/NIGMS NIH HHS/United States GR - R01 AI074967/AI/NIAID NIH HHS/United States GR - P01 AI090935/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20120923 PL - England TA - Nature JT - Nature JID - 0410462 RN - 0 (Codon) RN - 0 (Nuclear Proteins) RN - 0 (RNA, Viral) RN - 0 (SLFN11 protein, human) RN - 0 (Viral Proteins) RN - 9014-25-9 (RNA, Transfer) SB - IM CIN - Nat Rev Urol. 2012 Nov;9(11):605. PMID: 23045266 CIN - Nat Rev Microbiol. 2012 Nov;10(11):732. PMID: 23070553 MH - Cell Line MH - Cells, Cultured MH - Codon/*genetics/immunology MH - Gene Expression Regulation, Viral/*genetics MH - HEK293 Cells MH - HIV-1/*genetics/growth & development/immunology/metabolism MH - Humans MH - Immunity, Innate MH - Nuclear Proteins/immunology/*metabolism MH - Protein Biosynthesis/*genetics/immunology MH - RNA, Transfer/genetics/metabolism MH - RNA, Viral/genetics/metabolism MH - Reverse Transcription MH - Species Specificity MH - Substrate Specificity MH - Viral Proteins/*biosynthesis/*genetics MH - Virus Integration PMC - PMC3705913 MID - NIHMS475634 COIS- The authors declare no competing financial interests. EDAT- 2012/09/25 06:00 MHDA- 2012/12/27 06:00 PMCR- 2013/11/01 CRDT- 2012/09/25 06:00 PHST- 2011/11/22 00:00 [received] PHST- 2012/07/23 00:00 [accepted] PHST- 2012/09/25 06:00 [entrez] PHST- 2012/09/25 06:00 [pubmed] PHST- 2012/12/27 06:00 [medline] PHST- 2013/11/01 00:00 [pmc-release] AID - nature11433 [pii] AID - 10.1038/nature11433 [doi] PST - ppublish SO - Nature. 2012 Nov 1;491(7422):125-8. doi: 10.1038/nature11433. Epub 2012 Sep 23.